Liver enzyme elevations during statin–ezetimibe therapy in ABCG2 c.421C>A variant carriers: a case series and narrative review

Livija Šimičević, Lana Ganoci, Ena Karačić, Tamara Božina, Ivan Pećin, Vladimir Trkulja, Nada Božina

Open source

DOI
10.3389/fphar.2026.1840055
Published
2026-10-05
Container
Frontiers in Pharmacology
Publisher
Frontiers Media SA
Open access
unknown

Credibility signals

uncertain Score 64/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.

Show all credibility signals

Cite this work

BibTeX

@article{allodium:10.3389/fphar.2026.1840055,
  title = {Liver enzyme elevations during statin–ezetimibe therapy in ABCG2 c.421C\>A variant carriers: a case series and narrative review},
  author = {Livija Šimičević and Lana Ganoci and Ena Karačić and Tamara Božina and Ivan Pećin and Vladimir Trkulja and Nada Božina},
  year = {2026},
  journal = {Frontiers in Pharmacology},
  doi = {10.3389/fphar.2026.1840055},
  url = {https://doi.org/10.3389/fphar.2026.1840055}
}

RIS

TY  - JOUR
TI  - Liver enzyme elevations during statin–ezetimibe therapy in ABCG2 c.421C>A variant carriers: a case series and narrative review
AU  - Livija Šimičević
AU  - Lana Ganoci
AU  - Ena Karačić
AU  - Tamara Božina
AU  - Ivan Pećin
AU  - Vladimir Trkulja
AU  - Nada Božina
PY  - 2026
JO  - Frontiers in Pharmacology
DO  - 10.3389/fphar.2026.1840055
UR  - https://doi.org/10.3389/fphar.2026.1840055
ER  - 

APA

Šimičević, L., Ganoci, L., Karačić, E., Božina, T., Pećin, I., Trkulja, V., & Božina, N. (2026). Liver enzyme elevations during statin–ezetimibe therapy in ABCG2 c.421C>A variant carriers: a case series and narrative review. Frontiers in Pharmacology. https://doi.org/10.3389/fphar.2026.1840055

Source records